🇺🇸 FDA
Pipeline program

Peginterferon alfa-2a

ML25588

Approved small_molecule active

Quick answer

Peginterferon alfa-2a for Hepatitis B, Chronic is a Approved program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
Hepatitis B, Chronic
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials